Study Stopped
Recruitment and retention challenges, coupled with our focus changing to a different direction.
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
Laser Therapy on Burned Skin
1 other identifier
observational
4
1 country
1
Brief Summary
The purpose of this study is to examine effects of laser therapy on blood flow and sweating responses in burn-injured skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2021
CompletedFirst Posted
Study publicly available on registry
July 1, 2021
CompletedStudy Start
First participant enrolled
July 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMarch 7, 2025
March 1, 2025
3.6 years
June 23, 2021
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin blood flow
Primary outcome variables will be skin blood flow and sweating responses from skin treated with laser therapy and adjacent untreated/uninjured skin.
Upwards to 6 months after the final laser treatment
Interventions
Standard of care laser treatment of burn-related injuries will be performed. This protocol assesses the effects of those treatments on skin blood flow and sweating responses.
Eligibility Criteria
Healthy individuals who undergo laser treatment for burn injuries
You may qualify if:
- years old
- Experience a severe burn injury that warrant laser therapy.
- Free of any significant underlying medical problems based upon a detailed medical history and physical exam
You may not qualify if:
- Known heart disease
- Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia.
- Abnormality detected on routine screening suggestive of cardiac ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram.
- Subject with a body mass index \>35 kg/m2
- Pregnant or planning to become pregnant within the subsequent 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
June 23, 2021
First Posted
July 1, 2021
Study Start
July 29, 2021
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
March 7, 2025
Record last verified: 2025-03